A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

Clinical trial NCT00922883 · COMPLETED

Trial details

NCT number: NCT00922883
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia, Aplastic Anemia, Hypoplastic Thrombocytopenia

Start date: 2009-05-29
Primary completion: 2013-05-07
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.